home / stock / nlnk / nlnk short
Short Information | NewLink Genetics (NASDAQ:NLNK)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,174,196 |
Total Actual Volume | 8,770,275 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 58,710 |
Average Short Percentage | 12.69% |
Is there a NLNK Short Squeeze or Breakout about to happen?
See the NLNK Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $1.63 | $1.58 | $1.65 | $1.57 | 183,508 | 21,116 | 11.51% |
02-11-2020 | $1.63 | $1.62 | $1.64 | $1.56 | 185,803 | 17,688 | 9.52% |
02-10-2020 | $1.65 | $1.61 | $1.67 | $1.57 | 298,310 | 24,088 | 8.07% |
02-07-2020 | $1.75 | $1.66 | $1.75 | $1.64 | 302,819 | 26,545 | 8.77% |
02-06-2020 | $1.74 | $1.75 | $1.7636 | $1.71 | 237,213 | 25,148 | 10.6% |
02-05-2020 | $1.76 | $1.75 | $1.78 | $1.68 | 305,280 | 50,511 | 16.55% |
02-04-2020 | $1.68 | $1.74 | $1.77 | $1.66 | 628,781 | 129,356 | 20.57% |
02-03-2020 | $1.69 | $1.66 | $1.78 | $1.62 | 350,412 | 55,685 | 15.89% |
01-31-2020 | $1.63 | $1.64 | $1.67 | $1.56 | 509,952 | 60,281 | 11.82% |
01-30-2020 | $1.65 | $1.63 | $1.6694 | $1.58 | 390,862 | 44,069 | 11.27% |
01-29-2020 | $1.73 | $1.65 | $1.75 | $1.63 | 425,883 | 42,027 | 9.87% |
01-28-2020 | $1.72 | $1.72 | $1.83 | $1.67 | 425,682 | 62,813 | 14.76% |
01-27-2020 | $1.74 | $1.71 | $1.82 | $1.71 | 459,260 | 69,759 | 15.19% |
01-24-2020 | $2.00 | $1.82 | $2.01 | $1.82 | 591,347 | 61,085 | 10.33% |
01-23-2020 | $2.03 | $2.00 | $2.03 | $1.94 | 333,206 | 27,997 | 8.4% |
01-22-2020 | $2.30 | $2.04 | $2.33 | $2.01 | 662,357 | 76,078 | 11.49% |
01-21-2020 | $2.04 | $2.26 | $2.40 | $2.04 | 1,210,301 | 171,477 | 14.17% |
01-17-2020 | $1.99 | $2.04 | $2.08 | $1.9301 | 681,501 | 134,382 | 19.72% |
01-16-2020 | $1.97 | $1.99 | $2.10 | $1.94 | 287,269 | 47,075 | 16.39% |
01-15-2020 | $1.98 | $1.99 | $2.0583 | $1.93 | 300,529 | 27,016 | 8.99% |
News, Short Squeeze, Breakout and More Instantly...
Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock PR Newswire NEW ORLEANS ...
AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced the appointment of Joseph S. McCracken, DVM, MS to the company's Board of Directors, effective March 23...
- Combined company, Lumos Pharma, Inc., to trade on Nasdaq under the stock symbol “LUMO” - Phase 2b trial expected to be initiated mid-2020 evaluating oral therapeutic candidate LUM-201 (ibutamoren) in Pediatric Growth Hormone Deficiency (PGHD) - Projected combined cash ...